StopDown
Kapiva logo
New fund · 23 January 2026KapivaAyurvedic nutrition and wellness productskapiva.in ↗

Kapiva launches Rs 50 crore innovation fund

By · Editor ·

Founded 2016
  • Kapiva sells Ayurvedic supplements, gummies, juices, teas, and skincare with over 100 products
  • It commits up to Rs 50 crore for an innovation fund supporting research from early-stage to near-commercialisation
  • The fund draws from Kapiva's recent $60 million Series D round, and the company is preparing for an IPO

What happened

  • Kapiva has launched an innovation fund with a commitment of up to Rs 50 crore.
  • The fund supports projects from early research to near-commercialisation.
  • Cheque sizes range from Rs 50 lakh for early-stage research to Rs 4-6 crore for late-stage programmes.
  • Focus areas include novel formulations, standardisation, phytochemistry, AI applications in Ayurveda, and clinical studies.
  • Eligible applicants are research institutions, PhD scholars, clinicians, hospitals, labs, incubators, and early-stage startups.
  • Applications open via a dedicated portal; proposals are evaluated by Kapiva's R&D leadership and external experts.
  • Kapiva offers capital, mentorship, access to clinical and research infrastructure, and regulatory guidance.
  • Kapiva plans to expand its R&D facility in Bengaluru as part of the initiative.

Why it matters

  • The fund aims to make Ayurveda outcome-driven and evidence-backed, according to co-founder Ameve Sharma.
  • Capital for the fund is drawn from Kapiva's most recent fundraise – a $60 million Series D round in September 2025.
  • Kapiva is preparing for an IPO and plans to go public in the next two to three years.
  • The company already runs in-house R&D with clinical trials and collaborates with institutions like THSTI and Manipal Hospitals.

The business

  • Kapiva sells Ayurvedic nutrition and wellness products including supplements, gummies, capsules, juices, teas, and skincare.
  • It has over 100 products and offers consultations with Ayurvedic doctors.
  • Top categories are diabetes care, gym and sports nutrition, energy, liver and heart health; diabetes supplements are the highest-selling.
  • Sales channels include a D2C website, online marketplaces, and offline retail stores.
  • Kapiva runs in-house R&D with clinical trials on flagship products and a dedicated research team.
  • It collaborates with THSTI (Ministry of Science and Technology), Manipal College of Pharmaceutical Sciences, and Manipal Hospitals.

The founders

Ameve Sharma

co-founder
  • Co-founder of Kapiva.
  • Says the innovation fund aims to make Ayurveda outcome-driven and evidence-backed.

Shrey Badhani

co-founder
  • Co-founded Kapiva.

In numbers

Rs 50 croreFund size commitment · 2026
Rs 50 lakhCheque size for early-stage research · 2026
Rs 4-6 croreCheque size for late-stage programmes · 2026
$120 millionTotal raised to date · 2026
$60 millionSeries D amount · 2025

What happens next

  • Kapiva plans to expand its R&D facility in Bengaluru as part of the initiative.
  • Kapiva is preparing for an IPO and plans to go public in the next two to three years.

Earlier rounds

  • September 2025 · Series D · $60 million · led by 360 ONE Asset and Vertex Growth

Words to know

phytochemistry
The study of chemicals derived from plants.
pre-clinical studies
Research done before testing on humans, often in labs or on animals.
clinical studies
Research involving human volunteers to test treatments or products.
bioactive enhancement
Improving the active compounds in a product to make it more effective.

The numbers around it

Healthcare & Life Sciences in January 2026: 12 rounds with a disclosed amount, $99.0 million in all; the biggest was Sukino ($31M). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
  • IPO: An IPO, or initial public offering, is the first time a company sells its shares to the public and lists on a stock exchange. In India SEBI supervises it and the shares trade on the NSE and BSE. A retail investor can bid up to ₹2 lakh, and the issue stays open for three working days.

Everything on Kapiva → · All startup news on 23 January 2026 →

Is this Kapiva? Get your “Featured on StopDown” badge →